Challenging the Current Approaches to Multiple Myeloma-Related Bone Disease: From Bisphosphonates to Target Therapy

E-ISSN： 1873-5576|9|7|854-870

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.9, Iss.7, 2009-01, pp. : 854-870

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Identification of New Targets for Therapy of Osteolytic Bone Disease in Multiple Myeloma

Current Drug Targets, Vol. 6, Iss. 6, 2005-09 ,pp. : 701-711

Bentham Science Publishers

Access to resources Recommend Favorite

Current Drug Therapy for Multiple Myeloma

By Huang Y-W. Hamilton A. Arnuk O.J. Chaftari P. Chemaly R.

Drugs, Vol. 57, Iss. 4, 1999-04 ,pp. : 485-506

Adis International

Access to resources Recommend Favorite

From Target Therapy to miRNA Therapeutics of Human Multiple Myeloma: Theoretical and Technological Issues in the Evolving Scenario

Current Drug Targets, Vol. 14, Iss. 10, 2013-09 ,pp. : 1144-1149

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic benefit of bisphosphonates in the management of prostate cancer-related bone disease

By Dawson Nancy A

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 705-716

Informa Healthcare

Access to resources Recommend Favorite

The Clinical and Cost Considerations of Bisphosphonates in Preventing Bone Complications in Patients with Metastatic Breast Cancer or Multiple Myeloma

By McCloskey E.V.

Drugs, Vol. 61, Iss. 9, 2001-01 ,pp. : 1253-1274

Adis International

Access to resources Recommend Favorite